Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus
✍ Scribed by J. Rosenstock; M. Niggli; M. Maldonado-Lutomirsky
- Book ID
- 109044789
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 134 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1462-8902
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract __Background__: The aim of this study was to explore the relationship of serum profile of adipokines with cardiovascular risk factors and anthropometric parameters in patients with diabetes mellitus type 2. __Subjects__: A population of 108 obese patients with DM2 was analyzed. A comple
## Abstract ## Background Type 2 diabetes is a growing problem in Mexico. The present study was undertaken to evaluate the efficacy and safety of rosiglitazone 2 mg or 4 mg twice daily (bd) in combination with metformin 2.5 g/day in Mexican patients whose type 2 diabetes was inadequately controlle